ODAC Meeting

11/30/01


Click here to start


Table of Contents

ODAC Meeting

Challenges in Pediatric Cancer Drug Development

Phase 1 Design: Optimum Biologic Dose

Phase 1 Design: Starting Dose

Phase 1 Trial Design: Pharmacology

Challenges in Pediatric Cancer Drug Development

Efficacy Extrapolation

Challenges in Pediatric Cancer Drug Development

Combination Studies

Combination Studies

RMP-7/Carboplatin Phase I Trial

Genasense Phase 1 Trial

Challenges in Pediatric Cancer Drug Development

Challenges in Pediatric Cancer Drug Development

Prioritization

Pre-clinical Models

Challenges in Pediatric Cancer Drug Development

Author: Peter C. Adamson